Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin
Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
SpringerOpen
2024-11-01
|
| Серія: | Future Journal of Pharmaceutical Sciences |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s43094-024-00746-7 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|